Skip to main content
James Freeman, MD, Cardiology, New Haven, CT, Yale-New Haven Hospital

JamesVan Rensselaer HuntFreemanMDMPH, MS

Cardiology New Haven, CT

Adult Congenital Heart Disease, Cardiac Electrophysiology

Assistant Professor of Medicine (Cardiac Electrophysiology) Yale University School of Medicine

Telehealth Available

Overview of Dr. Freeman

Dr. James Freeman is a cardiologist in New Haven, CT and is affiliated with Yale-New Haven Hospital. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 14 years. He is one of 280 doctors at Yale-New Haven Hospital who specialize in Cardiology. He has more than 100 publications and over 500 citings.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Clinical Cardiac Electrophysiology, 2011 - 2013
  • Stanford University School of Medicine
    Stanford University School of MedicineM.S., Health Services Research, 2011
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2007 - 2010
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2003 - 2006
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2003
  • Dartmouth College
    Dartmouth CollegeB.A., Biochemistry and Molecular Biology/English, Summa cum Laude, 1997

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2004 - Present
  • CT State Medical License
    CT State Medical License 2013 - 2025
  • American Board of Internal Medicine Clinical Cardiac Electrophysiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
  • Best Poster Award American College of Cardiology Scientific Sessions, 2013
  • Edwin L. Alderman Award for Excellence in Clinical Research Stanford Division of Cardiovascular Medicine, 2010
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Digoxin and Risk of Death in Adults with Atrial Fibrillation: The ATRIA-CVRN Study  
    Freeman JV, Reynolds K, Fang M, Udaltsova N, Steimle A, Pomernacki, NK, Borowsky, LH, Harrison TN, Singer DE, Go AS, Circ Arrhythm Electrophysiol, 1/20/2014
  •  
    Chang TI, Yang J, Freeman JV, Hlatky MA, Go AS, J Card Fail, 1/1/2013
  • Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation  
    Hess PL, Kim S, Piccini JP, Allen LA, Ansell JE, Chang P, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Thomas L, Peterson ED, Fonarow GC, Am J Med, 1/1/2013
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Cost-Effectiveness of Single-Chamber Compared with Dual-Chamber and Single-Lead with Atrial Sensing Implantable Cardioverter Defibrillators
    James V. Freeman, Michael J. Harvey, Jay P. Thaker, David Hutton, American Heart Association Scientific Sessions, 1/1/2014
  • Long-Term Device-Related Adverse Events After Implantable Cardioverter-Defibrillator Therapy
    Isuru Ranasinghe, Craig Parzynski, James V Freeman, Rachel P Dreyer, Joseph S Ross, Joseph G Akar, Harlan M Krumholz, Jeptha P. Curtis, American Heart Association Scientific Sessions, 1/1/2014
  • Impact of the 2014 Atrial Fibrillation Guideline on the Proportion of Patients Recommended for Oral Anticoagulation
    Emily C O'Brien, Sunghee Kim, Paul L. Hess, James V. Freeman, Laine Thomas, Gregg C. Fonarow, Jack E. Ansell, Peter R. Kowey, Elaine M. Hylek, Kenneth W. Mahaffey, Pau..., American Heart Association Scientific Sessions, 1/1/2014
  • Join now to see all

Lectures

  • Outcomes in ICD Populations 
    1/1/2014
  • Digoxin and Risk of Death in Adults with Atrial Fibrillation: The ATRIA-CVRN Study 
    1/1/2013
  • Minimally Invasive Surgical Ablation is Better than Catheter Ablation of Atrial Fibrillation 
    1/1/2013
  • Join now to see all

Other

  • Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation: Results from RAAFT-2. Arrhythmias & Clinical EP Clinical Top... 
    Freeman JV
    1/1/2014

Press Mentions

  • Yale New Haven Doctors Use Device to Trap Blood Clots, Prevent Stroke
    Yale New Haven Doctors Use Device to Trap Blood Clots, Prevent StrokeJanuary 13th, 2018
  • Atrial Fibrillation Hospitalizations Rise as Mortality Rates Decline
    Atrial Fibrillation Hospitalizations Rise as Mortality Rates DeclineFebruary 2nd, 2017
  • Device May Be Better Than Drugs for Irregular Heartbeat
    Device May Be Better Than Drugs for Irregular HeartbeatJune 16th, 2016
  • Join now to see all

Hospital Affiliations